抗性高血压治疗外血管膜化
Hyukjin Park1, Eu Chang Hwang2, Jung Ki Jo3
1Division of Cardiology, Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Republic of Korea.
血管外脏缩 (eRDN) 有效降低了两名患有严重抗性高血压的患者的血压. 这种新的方法减少了药物需求,没有出现并发症,提供了一个有前途的替代治疗方法.
科学领域:
- 心血管医学 心血管医学
- 干预心脏病学 干预心脏病学
- 腎臟病學 (nephrology) 是一種醫學.
背景情况:
- 耐性高血压,定义为尽管服用了三种或更多的抗高血压药物,但血压仍无法控制,这构成了重大的临床挑战.
- 血管内缺血已经证明有效性有限,需要探索替代治疗策略.
- 血管外 (eRDN) 的发展旨在克服与血管内方法相关的局限性.
更多相关视频
04:37Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
Published on: June 6, 2025
11:08Novel Approach for Simultaneous Recording of Renal Sympathetic Nerve Activity and Blood Pressure with Intravenous Infusion in Conscious, Unrestrained Mice.
Published on: February 14, 2018
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Direct Renin Inhibitors
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Heart Failure Drugs: Diuretics
Antihypertensive Drugs: Action of Diuretics
Heart Failure V: Medical Management
